Can home tests replace lab draws for rare disease patients?
NCT ID NCT07459582
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to see if a home lactate meter and a standard glucose meter give accurate readings compared to lab tests in people with glycogen storage disease types Ia, Ib, and XI. Ten participants will have an 8-hour hospital stay with hourly blood draws and finger-stick tests. The goal is to make monitoring easier and more convenient for patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLYCOGEN STORAGE DISEASE TYPE I are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Connecticut Children's
RECRUITINGHartford, Connecticut, 06106, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a diabetes drug tame dangerous blood sugar drops in a rare metabolic disorder?
- Newborn screening study aims to catch rare diseases at birth
- Diabetes drug shows promise for rare immune disorder
- Cornstarch timing may be key for rare sugar disorder
- Could a less strict diet improve life for adults with rare glycogen storage disease?
- Can a simple Finger-Stick replace lab tests for rare metabolic disease?